---
title: "Studio City plans to establish a private hospital focusing on imaging and diagnostic medical services"
description: "Melco Resorts & Entertainment plans to open a private hospital focused on imaging and diagnostic medical services at Studio City in Macau, covering an area of 12,618 square feet. The initial agreement"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257652532.md"
published_at: "2025-09-17T04:37:46.000Z"
---

# Studio City plans to establish a private hospital focusing on imaging and diagnostic medical services

> Melco Resorts & Entertainment plans to open a private hospital focused on imaging and diagnostic medical services at Studio City in Macau, covering an area of 12,618 square feet. The initial agreement signed with ZhiZhi Imaging is for 10 years, effective from October 1, 2023, with both parties able to negotiate an extension. ZhiZhi Imaging is required to pay a base monthly fee, revenue-sharing fees, and management fees, and may acquire medical equipment at a symbolic price upon the expiration of the agreement. This move is related to the non-gaming project investment requirements of the Macau gaming concession contract

Melco Resorts & Entertainment (MLCO.US) announced plans to open a private hospital within the Studio City integrated resort in Macau, focusing on imaging and diagnostic medical services, with a total area of 12,618 square feet.

Melco's parent company, Melco International Development (00200.HK), stated in the announcement that it has signed an operating agreement with iRad Imaging and Diagnostic Medical Center. iRad Imaging is a related company of Melco's Chairman and CEO, Lawrence Ho. The initial operating period for the hospital is 10 years, effective from October 1 of this year; after the agreement expires, both parties can negotiate two extensions, each for five years.

Studio City Commercial will purchase and install several medical devices for iRad Imaging to operate on-site. iRad Imaging is required to pay Melco a basic fee: first, a base monthly fee starting at approximately MOP 695,000, covering rent and equipment usage fees; second, a revenue-sharing fee, which is payable if 1.5% of monthly revenue exceeds the base monthly fee; third, a management fee, which will be charged starting from the fourth year after the agreement takes effect. Upon expiration of the agreement, iRad Imaging has the right to purchase the aforementioned medical equipment at a "symbolic price."

This cooperation agreement is directly related to the ten-year gaming concession contracts signed by six gaming concessionaires in Macau in 2022. According to the contract requirements, starting from January 1, 2023, the six operators must collectively invest MOP 108.8 billion in the development of non-gaming projects

### Related Stocks

- [MSC.US - Studio City](https://longbridge.com/en/quote/MSC.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 美國與印尼敲定貿易協議 輸美商品關税降至 19% | 美國與印尼達成貿易協議，印尼輸美商品關税降至 19%。協議於去年 7 月宣佈，印尼在協議前面臨高達 32% 的關税威脅。協議內容包括豁免美國企業遵守自製率規定，並解決美國農產品在印尼的貿易障礙。此外，印尼同意採購價值 330 億美元的美國能 | [Link](https://longbridge.com/en/news/276423471.md) |
| 陶冬：人民幣資產機會來了 科技自主牛市顯現 警示美債風險「黃金買貴不會買錯」 | 陶冬表示，人民幣資產機會已來，科技自主牛市顯現，當前是「資產為王」的時代，關注遠離央行控制的資產和科技突破。預計美聯儲將維持寬鬆政策，但短期內可能觀察。美債市場面臨風險，傳統零風險資產邏輯已被顛覆，需警惕未來利率可能降至 3% 左右。 | [Link](https://longbridge.com/en/news/276028666.md) |
| Anthropic 發布新 AI 模型 Claude Sonnet 4.6 幻覺和奉承傾向較低 | Anthropic 發布新 AI 模型 Claude Sonnet 4.6，旨在提升 AI 工具的任務處理效率。該模型能執行多步驟操作，如填寫網頁表單，並在多個瀏覽器標籤間協調信息。Sonnet 4.6 在編程方面更可靠，幻覺和奉承傾向較低 | [Link](https://longbridge.com/en/news/276406320.md) |
| 黃仁勳稱將發佈「令世界驚訝」新晶片「所有技術都已經逼近極限」 | 英偉達執行長黃仁勳在接受《韓國經濟日報》採訪時透露，將於 2026 年 3 月 16 日在聖何塞的 GTC 大會上發布一款「令世界驚訝」的新晶片。他表示，所有技術都已逼近極限，但有信心通過團隊合作克服挑戰。新晶片可能基於 Rubin 架構或 | [Link](https://longbridge.com/en/news/276297645.md) |
| 中國物流「雙面」進化論：從草莽江湖到存量博弈突圍｜陳新燊 | 中國物流行業經歷了從草莽創業到全球領先的轉變，年業務量在 2026 年突破 2,000 億件，成為世界第一。然而，行業面臨利潤低迷、高附加值瓶頸及國際市場受限等挑戰。儘管社會物流成本與 GDP 比率為 13.9%，與美日相比仍顯低效，但中國 | [Link](https://longbridge.com/en/news/276017585.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.